Oxytetracycline and Flunixin Meglumine Injection 30% + 2%
Indications
For the treatment of bovine respiratory disease caused by Mannheimia (Pasteurella) haemolytica where an anti-inflammatory and anti-pyretic effect is required.
Administration and Dosage
Indicated for deep intramuscular administration to cattle. The recommended dosage is 1 ml per 10 kg bodyweight (equivalent to 2 mg/kg flunixin and 30 mg/kg oxytetracycline) on a single occasion.
Maximum volume per injection site: 15ml. If concurrent treatment is administered use a separate injection site.
Additional therapy with an NSAID may be administered after 24 hours if required.
Avoid the introduction of contamination.
Contraindications
Do not use in in animals suffering from cardiac, hepatic, or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding.
Do no use in dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of increased renal toxicity.
Do not use in cases of hypersensitivity to the active substances or to any of the excipients.
Do not use the veterinary medicinal product where there are signs of blood dyscrasias or haemostasis alteration.
Side Effects
The use of tetracyclines during the period of tooth and bone development, including late pregnancy, may lead to discolouration.
Although the product is well tolerated, occasionally a local reaction of a transient nature may be observed.
Hypersensitivity reactions (collapse) may occur very rarely.
Withdrawal Period
Meat and offal: 35 days.
Not authorised for use in cattle producing milk for human consumption.
Storage
Store below 30℃. Protect from light.
For Veterinary Use Only
